Abstract

Phase IIa Study of Single-Agent MOR208 in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Discovery of Candidate Predictors of Response to Tazemetostat in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma Using NGS Technology on ctDNA Samples Collected Pre-Treatment
...
Blood | VOL. 130
, et. al. ...
25 Jun 2021
A Phase IIa, Open-Label, Multicenter Study of Single-Agent Tafasitamab (MOR208), an Fc-Optimized Anti-CD19 Antibody, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma: Long-Term Follow-up, Final Analysis
Wojciech Jurczak ... Kristie Blum
Blood | VOL. 134
Wojciech Jurczak, et. al.Wojciech Jurczak ... Kristie Blum
13 Nov 2019
A Phase IIa, Open-Label, Multicenter Study of Single-Agent MOR00208, an Fc-Optimized Anti-CD19 Antibody, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma
Kristie A Blum ... Wojciech Jurczak
Blood | VOL. 124
Kristie A Blum, et. al.Kristie A Blum ... Wojciech Jurczak
06 Dec 2014
Subcutaneous Epcoritamab Induces Complete Responses with an Encouraging Safety Profile across Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Subtypes, Including Patients with Prior CAR-T Therapy: Updated Dose Escalation Data
Martin Hutchings ... Pieternella J Lugtenburg
Blood | VOL. 136
Martin Hutchings, et. al.Martin Hutchings ... Pieternella J Lugtenburg
05 Nov 2020
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Chronic graft-versus-host disease: Unresolved complication or ancient history?
Joseph A Pidala ... Bruce R Blazar
Blood | VOL. -
Joseph A Pidala, et. al.Joseph A Pidala ... Bruce R Blazar
15 Jul 2024
Blood coagulation factor IX: structural insights impacting hemophilia B therapy
Mettine H A Bos ... Dougald M Monroe
Blood | VOL. -
Mettine H A Bos, et. al.Mettine H A Bos ... Dougald M Monroe
12 Jul 2024
Hope for Motherhood: Pregnancy After Allogeneic Hematopoietic Cell Transplantation - a National Multicenter Study.
Katja Sockel ... Johannes Schetelig
Blood | VOL. -
Katja Sockel, et. al.Katja Sockel ... Johannes Schetelig
12 Jul 2024
Risk Prediction for Clonal Cytopenia: Multicenter Real-World Evidence
Zhuoer Xie ... Aref Al-Kali
Blood | VOL. -
Zhuoer Xie, et. al.Zhuoer Xie ... Aref Al-Kali
12 Jul 2024
View more papers